Praxis Precision Medicines (PRAX) News Today → Don’t make this retirement mistake (From Sasco Gold LLC) (Ad) Free PRAX Stock Alerts $40.56 +0.02 (+0.05%) (As of 06/10/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 10 at 11:50 AM | marketbeat.comVerition Fund Management LLC Sells 8,356,839 Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX)Verition Fund Management LLC trimmed its stake in Praxis Precision Medicines, Inc. (NASDAQ:PRAX - Free Report) by 92.2% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 703,000 shares of the company's stock after selling 8,356,839 shJune 8 at 8:43 AM | americanbankingnews.comPraxis Precision Medicines (NASDAQ:PRAX) Shares Down 4.8% June 7, 2024 | marketbeat.comCIBC Asset Management Inc Sells 1,652,042 Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX)CIBC Asset Management Inc cut its holdings in Praxis Precision Medicines, Inc. (NASDAQ:PRAX - Free Report) by 90.5% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 173,868 shares of the company's stock afJune 6, 2024 | marketbeat.comPraxis Precision Medicines (NASDAQ:PRAX) Stock Price Down 4.8%Praxis Precision Medicines (NASDAQ:PRAX) Shares Down 4.8%June 4, 2024 | globenewswire.comPraxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)May 23, 2024 | uk.investing.comPraxis Precision Medicines shares maintain price targetMay 22, 2024 | msn.comPraxis Precision Medicines (NASDAQ:PRAX): A Wild Rollercoaster RideMay 17, 2024 | globenewswire.comPraxis Precision Medicines to Participate in Upcoming Investor ConferencesMay 16, 2024 | markets.businessinsider.comCritical Insights From Praxis Precision Medicine Analyst Ratings: What You Need To KnowMay 16, 2024 | marketbeat.comPraxis Precision Medicines (NASDAQ:PRAX) Trading Up 4.9%Praxis Precision Medicines (NASDAQ:PRAX) Trading Up 4.9%May 16, 2024 | marketbeat.comPraxis Precision Medicines (NASDAQ:PRAX) Given Buy Rating at Truist FinancialTruist Financial restated a "buy" rating and set a $150.00 price objective on shares of Praxis Precision Medicines in a research report on Thursday.May 16, 2024 | markets.businessinsider.comBuy Rating Backed by Robust Pipeline and Market Opportunity for Praxis Precision MedicinesMay 15, 2024 | marketbeat.comPraxis Precision Medicines, Inc. to Post Q1 2025 Earnings of ($1.89) Per Share, HC Wainwright Forecasts (NASDAQ:PRAX)Praxis Precision Medicines, Inc. (NASDAQ:PRAX - Free Report) - Equities research analysts at HC Wainwright issued their Q1 2025 earnings per share (EPS) estimates for shares of Praxis Precision Medicines in a report issued on Tuesday, May 14th. HC Wainwright analyst D. Tsao anticipates that the cMay 14, 2024 | marketbeat.comPraxis Precision Medicines (NASDAQ:PRAX) Rating Reiterated by HC WainwrightHC Wainwright reaffirmed a "buy" rating and issued a $105.00 price objective on shares of Praxis Precision Medicines in a research report on Tuesday.May 14, 2024 | finance.yahoo.comWe're Hopeful That Praxis Precision Medicines (NASDAQ:PRAX) Will Use Its Cash WiselyMay 13, 2024 | marketbeat.comPraxis Precision Medicines (NASDAQ:PRAX) Shares Gap Down to $48.78Praxis Precision Medicines (NASDAQ:PRAX) Shares Gap Down to $48.78May 13, 2024 | marketwatch.comPraxis Precision Medicines Shares Drop 5% After 1Q Results Miss ExpectationsMay 13, 2024 | finanznachrichten.dePraxis Precision Medicines, Inc.: Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2024 Financial ResultsMay 13, 2024 | msn.comPraxis Precision Medicines GAAP EPS of -$2.84 misses by $0.75, revenue of $0.43M misses by $1.33MMay 13, 2024 | globenewswire.comPraxis Precision Medicines Provides Corporate Update and Reports First Quarter 2024 Financial ResultsMay 12, 2024 | markets.businessinsider.comPraxis Precision Medicines is about to announce earnings — here's what Wall Street expectsMay 11, 2024 | marketbeat.comPraxis Precision Medicines (PRAX) Scheduled to Post Earnings on MondayPraxis Precision Medicines (NASDAQ:PRAX) will be releasing earnings before the market opens on Monday, May 13, Zacks reports.May 10, 2024 | globenewswire.comPraxis Precision Medicines to Report First Quarter 2024 Financial Results on Monday, May 13, 2024May 3, 2024 | globenewswire.comPraxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)May 1, 2024 | msn.comBaird Initiates Coverage of Praxis Precision Medicines (PRAX) with Outperform RecommendationMay 1, 2024 | marketbeat.comPraxis Precision Medicines (NASDAQ:PRAX) Now Covered by Analysts at Robert W. BairdRobert W. Baird began coverage on shares of Praxis Precision Medicines in a report on Wednesday. They set an "outperform" rating and a $117.00 price target for the company.April 30, 2024 | msn.comGoldman Sachs revamps "high-quality" stock picks listApril 30, 2024 | msn.comBankrupt national retailer pins hopes on popular new serviceApril 26, 2024 | tmcnet.comMedaptus and Banner Health Partner to Revolutionize Charge Processing with Charge Pro: Beyond Automation to Enhanced Efficiency and PrecisionApril 26, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Hookipa Pharma (HOOK), Praxis Precision Medicines (PRAX) and Blueprint Medicines (BPMC)April 26, 2024 | marketbeat.comHC Wainwright Reiterates Buy Rating for Praxis Precision Medicines (NASDAQ:PRAX)HC Wainwright reiterated a "buy" rating and issued a $105.00 price objective on shares of Praxis Precision Medicines in a report on Friday.April 22, 2024 | marketbeat.comPraxis Precision Medicines (NASDAQ:PRAX) Sees Strong Trading VolumePraxis Precision Medicines (NASDAQ:PRAX) Sees Unusually-High Trading VolumeApril 22, 2024 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: BioCryst (BCRX), Ironwood Pharma (IRWD)April 17, 2024 | msn.comWhy an ALS Drug Was Pulled From the MarketApril 17, 2024 | marketbeat.comPraxis Precision Medicines (NASDAQ:PRAX) Stock Price Down 2.6%Praxis Precision Medicines (NASDAQ:PRAX) Shares Down 2.6%April 12, 2024 | globenewswire.comPraxis Precision Medicines to Present on Ulixacaltamide at the American Academy of Neurology 2024 Annual MeetingApril 11, 2024 | marketbeat.comBrokers Offer Predictions for Praxis Precision Medicines, Inc.'s Q2 2024 Earnings (NASDAQ:PRAX)Praxis Precision Medicines, Inc. (NASDAQ:PRAX - Free Report) - Research analysts at Wedbush lifted their Q2 2024 earnings per share (EPS) estimates for Praxis Precision Medicines in a report released on Monday, April 8th. Wedbush analyst L. Chico now expects that the company will post earnings ofApril 9, 2024 | marketbeat.comPraxis Precision Medicines (NASDAQ:PRAX) Shares Down 2.5% Praxis Precision Medicines (NASDAQ:PRAX) Stock Price Down 2.5%April 8, 2024 | marketbeat.comPraxis Precision Medicines (NASDAQ:PRAX) Shares Up 5.1%Praxis Precision Medicines (NASDAQ:PRAX) Trading 5.1% HigherApril 5, 2024 | globenewswire.comPraxis Precision Medicines to Participate in Upcoming April ConferencesApril 3, 2024 | marketbeat.comPraxis Precision Medicines (NASDAQ:PRAX) Stock Price Down 6.1%Praxis Precision Medicines (NASDAQ:PRAX) Stock Price Down 6.1%April 2, 2024 | globenewswire.comPraxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)March 31, 2024 | marketbeat.comCitigroup Inc. Grows Holdings in Praxis Precision Medicines, Inc. (NASDAQ:PRAX)Citigroup Inc. increased its position in shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX - Free Report) by 44,585.5% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 83,115 shares of the company's stock after buyinMarch 28, 2024 | markets.businessinsider.comPraxis Precision Medicines Announces Pricing Of Underwritten Public OfferingMarch 28, 2024 | globenewswire.comPraxis Precision Medicines, Inc. Announces Pricing of $200 Million Public OfferingMarch 27, 2024 | globenewswire.comPraxis Precision Medicines, Inc. Announces Proposed Public OfferingMarch 27, 2024 | marketbeat.comPraxis Precision Medicines (NASDAQ:PRAX) Shares Down 3.8% Praxis Precision Medicines (NASDAQ:PRAX) Stock Price Down 3.8%March 26, 2024 | msn.comPraxis gains after mid-stage data for epilepsy candidateMarch 26, 2024 | markets.businessinsider.comPraxis Precision Medicines Reports Positive Results From PRAX-628 Study - Quick FactsMarch 26, 2024 | markets.businessinsider.comBuy Rating Affirmed for Praxis Precision Medicines’ PRAX-628 Based on Strong Clinical Trial Outcomes and Market Potential Get Praxis Precision Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for PRAX and its competitors with MarketBeat's FREE daily newsletter. Email Address Moonshot Coins for the Current Crypto Run (Ad)Did you see bitcoin crossed $70k again? Don't miss the next bull run. Because while Bitcoin and Ethereum steal all the headlines… It’s often the cryptos flying under the radar that turn small stakes into life-changing windfalls. Claim your free seat by clicking here now. PRAX Media Mentions By Week PRAX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PRAX News Sentiment▼0.760.75▲Average Medical News Sentiment PRAX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PRAX Articles This Week▼52▲PRAX Articles Average Week Get Praxis Precision Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for PRAX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Sage Therapeutics News Today Travere Therapeutics News Today COMPASS Pathways News Today MacroGenics News Today Repare Therapeutics News Today Geron News Today MorphoSys News Today Dyne Therapeutics News Today Agios Pharmaceuticals News Today MoonLake Immunotherapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PRAX) was last updated on 6/11/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredDON’T buy gold until you read thisIf you're an American who understands that your money is rotting away as you read this email… Then this is ...Sasco Gold LLC | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredMoonshot Coins for the Current Crypto RunDid you see bitcoin crossed $70k again? Don't miss the next bull run. Because while Bitcoin and Ethereum s...Crypto 101 Media | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | Sponsored